| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-07 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-07 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-05 |